Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will report its financial results for the fiscal 2014 fourth quarter and year ended September 30, 2014, on Tuesday, November 25, 2014, at 4:30 p.m. EST.
Help employers find you! Check out all the jobs and post your resume.
